Literature DB >> 3803741

Antibodies to insulin receptor followed by anti-idiotype. Antibodies to insulin in child with hypoglycemia.

D Elias, I R Cohen, Y Schechter, Z Spirer, A Golander.   

Abstract

A child presenting severe hypoglycemia despite low or normal secretion of insulin was found to have IgM antibodies to the insulin receptor. These antibodies stimulated lipogenesis in fat cells in vitro and competed with insulin for binding to insulin receptors. After treatment with glucocorticoids, the anti-receptor antibodies and the hypoglycemia both disappeared, and antibodies to insulin appeared in the patient's serum. The anti-insulin antibodies were isolated by affinity chromatography and were found to inhibit the anti-insulin-receptor antibodies that were present earlier. The interaction between the patient's anti-insulin antibodies and his anti-receptor antibodies suggests that these two species of antibodies are related as idiotypes and anti-idiotypes. We also studied the interaction of the hypoglycemic patient's anti-receptor antibodies with anti-insulin antibodies of a diabetic patient and with anti-insulin antibodies of mice immunized to insulin. The hypoglycemic patient's anti-receptor antibodies were neutralized by the diabetic patient's anti-insulin antibodies, indicating that anti-insulin antibodies with a common idiotype may arise in both diabetes and hypoglycemia. Moreover, mouse anti-insulin antibodies that interacted with mouse anti-receptor antibodies neutralized the hypoglycemic patient's anti-receptor antibodies. In contrast, mouse anti-insulin antibodies that did not interact with the mouse anti-receptor antibodies did not neutralize the hypoglycemic patient's anti-receptor antibodies. Thus, the human anti-insulin antibodies share an idiotype with a specific class of mouse anti-insulin antibodies.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3803741     DOI: 10.2337/diab.36.3.348

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

Review 1.  Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action.

Authors:  R De Pirro; P Borboni; M A Marini; A Montemurro; G Sesti; R Lauro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

2.  Desensitization of the insulin receptor by antireceptor antibodies in vivo is blocked by treatment of mice with beta-adrenergic agonists.

Authors:  D Elias; M Rapoport; I R Cohen; Y Shechter
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

3.  Autoantibodies to the insulin receptor are infrequent findings in type 1 (insulin-dependent) diabetes mellitus of recent onset.

Authors:  N Rochet; J L Sadoul; B Ferrua; J Kubar; J F Tanti; P Bougnères; B Vialettes; E Van Obberghen; Y Le Marchand-Brustel; P Freychet
Journal:  Diabetologia       Date:  1990-07       Impact factor: 10.122

4.  Polymorphism of insulin antibodies in six patients with insulin-immune hypoglycaemic syndrome.

Authors:  N Dozio; F Sodoyez-Goffaux; M Koch; B Ziegler; J C Sodoyez
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

5.  Hypoglycaemia induced by antibodies to insulin receptor following a bone marrow transplantation in an immunodeficient child.

Authors:  N Rochet; S Blanche; J C Carel; A Fischer; F L Deist; C Griscelli; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Diabetologia       Date:  1989-03       Impact factor: 10.122

Review 6.  Insulin autoimmune syndrome: from diagnosis to clinical management.

Authors:  Simona Censi; Caterina Mian; Corrado Betterle
Journal:  Ann Transl Med       Date:  2018-09

7.  Searching for the Culprit: When Diabetic Ketoacidosis Presents With Insulin Autoantibodies.

Authors:  Scarlette Garcia-Avila; Anish Samuel; Iqra Farooqi; Rajapriya Manickam; Mourad Ismail; Saleh I Khaddash; Sandra Gibiezaite
Journal:  AACE Clin Case Rep       Date:  2020-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.